Zhongzhu Medical Holdings Co Ltd - Asset Resilience Ratio

Latest as of June 2024: 2.95%

Zhongzhu Medical Holdings Co Ltd (600568) has an Asset Resilience Ratio of 2.95% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥80.00 Million
≈ $11.71 Million USD Cash + Short-term Investments

Total Assets

CN¥2.71 Billion
≈ $396.28 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2001–2023)

This chart shows how Zhongzhu Medical Holdings Co Ltd's Asset Resilience Ratio has changed over time. Check Zhongzhu Medical Holdings Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Zhongzhu Medical Holdings Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 600568 market cap.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥80.00 Million 2.95%
Total Liquid Assets CN¥80.00 Million 2.95%

Asset Resilience Insights

  • Limited Liquidity: Zhongzhu Medical Holdings Co Ltd maintains only 2.95% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Zhongzhu Medical Holdings Co Ltd Industry Peers by Asset Resilience Ratio

Compare Zhongzhu Medical Holdings Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
Drug Manufacturers - Specialty & Generic 1.54%
Alkem Laboratories Limited
NSE:ALKEM
Drug Manufacturers - Specialty & Generic 31.91%
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
Drug Manufacturers - Specialty & Generic 20.44%
Alkermes plc
F:8AK
Drug Manufacturers - Specialty & Generic 3.76%
Jilin Aodong Pharmaceutical Group Co Ltd
SHE:000623
Drug Manufacturers - Specialty & Generic 4.97%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Shanghai Haoyuan Chemexpress Co. Ltd. A
SHG:688131
Drug Manufacturers - Specialty & Generic 1.37%
Fujian Cosunter Pharmaceutical Co Ltd
SHE:300436
Drug Manufacturers - Specialty & Generic -2.56%

Annual Asset Resilience Ratio for Zhongzhu Medical Holdings Co Ltd (2001–2023)

The table below shows the annual Asset Resilience Ratio data for Zhongzhu Medical Holdings Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2023-12-31 7.62% CN¥230.00 Million
≈ $33.66 Million
CN¥3.02 Billion
≈ $441.75 Million
+6.68pp
2022-12-31 0.94% CN¥35.00 Million
≈ $5.12 Million
CN¥3.71 Billion
≈ $543.28 Million
-1.66pp
2021-12-31 2.61% CN¥116.24 Million
≈ $17.01 Million
CN¥4.46 Billion
≈ $652.33 Million
+2.52pp
2018-12-31 0.09% CN¥5.00 Million
≈ $731.66K
CN¥5.62 Billion
≈ $822.28 Million
-1.77pp
2017-12-31 1.86% CN¥135.38 Million
≈ $19.81 Million
CN¥7.27 Billion
≈ $1.06 Billion
-0.94pp
2016-12-31 2.80% CN¥200.00 Million
≈ $29.27 Million
CN¥7.14 Billion
≈ $1.04 Billion
+1.64pp
2015-12-31 1.16% CN¥50.00 Million
≈ $7.32 Million
CN¥4.29 Billion
≈ $628.05 Million
+1.15pp
2013-12-31 0.02% CN¥490.38K
≈ $71.76K
CN¥2.64 Billion
≈ $386.45 Million
-0.02pp
2012-12-31 0.04% CN¥961.54K
≈ $140.70K
CN¥2.25 Billion
≈ $329.78 Million
+0.02pp
2011-12-31 0.02% CN¥458.93K
≈ $67.16K
CN¥2.10 Billion
≈ $306.67 Million
-0.03pp
2010-12-31 0.05% CN¥998.00K
≈ $146.04K
CN¥2.12 Billion
≈ $310.88 Million
+0.04pp
2005-12-31 0.01% CN¥100.12K
≈ $14.65K
CN¥1.38 Billion
≈ $202.35 Million
-0.03pp
2004-12-31 0.04% CN¥300.00K
≈ $43.90K
CN¥771.64 Million
≈ $112.91 Million
-0.01pp
2003-12-31 0.05% CN¥300.00K
≈ $43.90K
CN¥569.42 Million
≈ $83.32 Million
+0.01pp
2002-12-31 0.04% CN¥200.00K
≈ $29.27K
CN¥478.20 Million
≈ $69.98 Million
-43.88pp
2001-12-31 43.92% CN¥202.18 Million
≈ $29.58 Million
CN¥460.31 Million
≈ $67.36 Million
--
pp = percentage points

About Zhongzhu Medical Holdings Co Ltd

SHG:600568 China Drug Manufacturers - Specialty & Generic
Market Cap
$659.06 Million
CN¥4.50 Billion CNY
Market Cap Rank
#10823 Global
#2947 in China
Share Price
CN¥2.26
Change (1 day)
-1.31%
52-Week Range
CN¥1.70 - CN¥3.21
All Time High
CN¥9.91
About

Zhongzhu Healthcare Holding Co.,Ltd engages in the research and development, production, and sale of drugs in China. The company offers ophthalmology drugs, including Pearl eye drops, Sodium Cromolyn eye drops, Acyclovir eye drops, Hydroxybenzone Hydrochloride eye drops, Acyclovir dispersible tablets, and Gatifloxacin tablets; and products related to tumor treatment. It is also involved in produc… Read more